MAZZARINO, Maria Clorinda
 Distribuzione geografica
Continente #
NA - Nord America 6.366
AS - Asia 2.402
EU - Europa 2.260
SA - Sud America 441
AF - Africa 336
Continente sconosciuto - Info sul continente non disponibili 143
OC - Oceania 5
Totale 11.953
Nazione #
US - Stati Uniti d'America 6.123
SG - Singapore 1.207
RU - Federazione Russa 730
CN - Cina 723
UA - Ucraina 413
IE - Irlanda 368
BR - Brasile 356
IT - Italia 203
CI - Costa d'Avorio 187
VN - Vietnam 182
CA - Canada 179
FR - Francia 122
NL - Olanda 116
SE - Svezia 88
DE - Germania 78
NG - Nigeria 51
IN - India 50
GB - Regno Unito 46
SN - Senegal 44
KR - Corea 39
MX - Messico 33
AR - Argentina 29
HK - Hong Kong 27
BD - Bangladesh 26
PL - Polonia 22
IQ - Iraq 21
ZA - Sudafrica 21
EC - Ecuador 17
CO - Colombia 16
TR - Turchia 15
CH - Svizzera 14
ID - Indonesia 14
IR - Iran 14
UZ - Uzbekistan 12
AT - Austria 11
JP - Giappone 11
CR - Costa Rica 10
VE - Venezuela 10
ES - Italia 9
KE - Kenya 9
MA - Marocco 9
PK - Pakistan 8
BE - Belgio 7
EU - Europa 7
MY - Malesia 7
SA - Arabia Saudita 7
GR - Grecia 6
AE - Emirati Arabi Uniti 5
JM - Giamaica 5
PH - Filippine 5
PY - Paraguay 5
BG - Bulgaria 4
BY - Bielorussia 4
DZ - Algeria 4
FI - Finlandia 4
HN - Honduras 4
JO - Giordania 4
NP - Nepal 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
KZ - Kazakistan 3
LT - Lituania 3
MT - Malta 3
NZ - Nuova Zelanda 3
OM - Oman 3
PS - Palestinian Territory 3
TN - Tunisia 3
AU - Australia 2
CL - Cile 2
CZ - Repubblica Ceca 2
EG - Egitto 2
IL - Israele 2
LB - Libano 2
NI - Nicaragua 2
PA - Panama 2
PE - Perù 2
RS - Serbia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BM - Bermuda 1
BO - Bolivia 1
BW - Botswana 1
CD - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
GY - Guiana 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
SV - El Salvador 1
TH - Thailandia 1
Totale 11.817
Città #
Dallas 1.125
Santa Clara 708
Singapore 708
Jacksonville 496
Chandler 405
Dublin 368
San Jose 321
Houston 318
Moscow 318
Ashburn 238
Chicago 227
Abidjan 187
Boardman 180
Council Bluffs 130
Beijing 123
Nanjing 118
Toronto 114
Amsterdam 109
Cambridge 108
Lawrence 107
Andover 106
Lauterbourg 100
Los Angeles 94
Des Moines 78
San Mateo 67
Catania 65
Ho Chi Minh City 63
Hefei 51
Grafing 47
Wilmington 46
Dakar 44
New York 44
Hanoi 39
Buffalo 38
Seoul 36
Hebei 35
Nanchang 35
Abuja 32
São Paulo 31
Saint Petersburg 30
The Dalles 27
Columbus 25
Jiaxing 25
Orem 25
Hong Kong 23
San Francisco 23
Shenyang 22
Civitanova Marche 19
Montreal 18
Ottawa 17
Tianjin 17
Atlanta 16
Boston 16
Brooklyn 16
Changsha 16
Florence 15
Lagos 15
Warsaw 15
Chennai 14
Rio de Janeiro 14
Ardabil 13
Johannesburg 13
Leawood 13
Augusta 12
Stockholm 12
Bremen 11
London 11
Seattle 11
Tokyo 11
Baghdad 10
Da Nang 10
Denver 10
Hangzhou 10
Kunming 10
Mexico City 10
Norwalk 10
Monmouth Junction 9
Mumbai 9
San José 9
Nairobi 8
Ningbo 8
Porto Alegre 8
Curitiba 7
Guangzhou 7
Haiphong 7
Jinan 7
Shanghai 7
Belo Horizonte 6
Bogotá 6
Erbil 6
Falls Church 6
Phoenix 6
Redondo Beach 6
Tashkent 6
Washington 6
Ankara 5
Brussels 5
Campinas 5
Charlotte 5
Dhaka 5
Totale 8.203
Nome #
Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders 424
The sex bias in systemic sclerosis: on the possible mechanisms underlying the female disease preponderance 324
Advances in targeting signal transduction pathways. 248
Absence of BRAF gene mutation in non-melanoma skin tumors 223
All trans retinoic acid sensitizes colon cancer cells to hyperthermia cytotoxic effects 180
Analysis of hepatitis C virus infection among health-care workers: an observational study 176
Analysis of BRAF mutation in primary and metastatic melanoma 170
Altered pattern of circulating matrix metalloproteinases -2,- 9 and tissue inhibitor of metalloproteinase -2 in patients with HCV-related chronic hepatitis. Relationship to histological features 170
Activation of the Osteopontin/Matrix Metalloproteinase-9 Pathway Correlates with Prostate Cancer Progression 167
Autosomal recessive hypercholesterolemia in a Sicilian kindred harboring the 432insA mutation of the ARH gene 165
Association between rs2294020 in X-linked CCDC22 and susceptibility to autoimmune diseases with focus on systemic lupus erythematosus 161
Beta-2-glycoprotein I is growth regulated and plays a role as survival factor for hepatocytes 160
Effect of levofloxacin treatment on semen hyperviscosity in chronic bacterial prostatitis patients 159
Analysis of G(-174) CIL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease 157
Association of TIMP-1 +372 SNP with digital ulcer manifestation in female systemic sclerosis patients 150
BRAF G469S mutation as indicator of neoplastic transformation in workers with UV exposure 148
B-cell neoplasia in the context of HCV infection: A distinct entity? 148
Detection of BRAF gene mutation in primary choroidal melanoma tissue 144
Analysis of MMP-9 gene polymorphism 1562C/T in patients suffering from systemic sclerosis with and without ulcers 141
Analysis of matrix metalloproteinase-9 gene polymorphism-1562 C/T in patients suffering from systemic sclerosis with and without ulcers 136
Biological therapy downregulates the heterodimer S100A8/A9 (calprotectin) expression in psoriatic patients 136
Proinflammatory circulating molecules in peripheral arterial disease 135
Analysis of osteopontin and matrix metalloproteinase-9 in prostate cancer 133
Co-regulated expression of matrix metalloproteinase-2 and transforming growth factor-beta in melanoma development and progression 132
CD155/Neel-5 immunolocallization in melanocytic skin lesions 128
Defective function of the fas apoptotic pathway in type 1 diabetes mellitus correlates with age at onset 127
Behavior of complement and anti-complement factors in the course of hepatic regeneration and degeneration 125
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response 124
Matrix metalloproteinases and their inhibitors as markers of inflammation and fibrosis in chronic liver disease 120
IL-2 RECEPTORS, NK AND LAK CYTOTOXICITY OF LYMPHOCYTES IN BREAST-CARCINOMA DURING PROLONGED THYMOPENTIN THERAPY 119
Liver immunolocalization and plasma levels of MMP-9 in non-alcoholic steatohepatitis (NASH) and hepatitis C infection 118
Soluble adhesion molecules and cytokines in children affected by recurrent infections of the upper respiratory tract 117
Vitamin D3: an ever green molecule 117
Biological therapy induces expression changes in Notch pathway in psoriasis 116
Role of BRAF mutations in hematopoietic malignancies and the induction of cytokine-independence-synergy with PI3K/Akt pathway 113
Analysis of TIMP-1 gene polymorphisms in Italian sclerodermic patients 113
Biologically induced improvement of PASI score is associated with a decline of S100A7 expression in psoriatic skin lesions. A preliminary immunohistochemical study 113
S100A7, Jab1, and p27 kip1 expression in psoriasis and S100A7 CRISPR-activated human keratinocyte cell line 112
Efficacy of an analysis of lymphocyte subsets in predicting the clinical response to alpha-interferon therapy in thalassaemia patients with chronic infection by hepatitis C virus: a pilot study 110
Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance 108
Contribution of Immunohistochemistry in Revealing S100A7/JAB1 Colocalization in Psoriatic Epidermal Keratinocyte 108
Plasma levels and zymographic activities of matrix metalloproteinases 2 and 9 in type II diabetics with peripheral arterial disease 107
Computational Evaluation of Yin Yang 1 Transcript Levels in the Spectrum of B-cell Neoplasia 107
Role of Hypoxia and Autophagy in MDA-MB-231 Invasiveness 104
IL2 and its receptors in elderly subjects on hemodialysis 103
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging 103
Osteopontin/Matrix metalloproteinases pathway is not activated in cervical carcinoma 101
Jagged-1 expression is downregulated in skin from biologic-treated psoriatic patients 100
CD155/Necl-5 immunolocalization in melanocytic skin lesions 100
Role of tissue inhibitor of metalloproteinases-1 in the development of autoimmune lymphoproliferation 100
IL-1beta, TNF-alpha and IL-6 release from monocytes in haemodialysis patients in relation to dialytic age 99
GIT-27 NO may be a potential therapeutic agent for melanoma treatment by inhibition of the transcription repressor YIN-YANG 99
S100A7: A rAMPing up AMP molecule in psoriasis 98
Osteopontin gene haplotypes correlate with multiple sclerosis development and progression 96
Effect of alpha-interferon on natural killer cell activity and lymphocyte subsets in thalassemia patients with chronic hepatitis C 95
Sensitization of cancer stem cells based on inhibiting key signal transduction pathways 95
Treatment with rapamycin ameliorates clinical and histological signs of protracted relapsing experimental allergic encephalomyelitis in Dark Agouti rats and induces expansion of peripheral CD4+CD25+Foxp3+ regulatory T cells 95
Persistent high plasma levels of interleukins 18 and 4 in children with recurrent infections of the upper respiratory tract 95
FOXP3, ICOS and ICOSL gene polymorphisms in systemic sclerosis: FOXP3 rs2294020 is associated with disease progression in a female Italian population 95
Rituximab for treatment of lymphoproliferative disorders associated with hepatitis C virus (HCV) infection 93
High circulating levels of cytockines (IL6 and TNFα), adhesion molecules (VICAM-1 and ICAM-1) and selectines in patients with peripheral arterial disease at rest and after a treadmill-test 92
Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer 92
Evaluation of circulating CD4⁺CD25⁺ and liver-infiltrating Foxp3⁺ cells in HCV-associated liver disease 91
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance. 91
IL-18 nelle infezioni virali ricorrenti in età pediatrica 91
Expression and localisation of osteopontin and prominin-1 (CD133) in patients with endometriosis 90
Inhibition of GSK-3 beta activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in breast cancer 90
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health 89
Effects of ischaemic stress on leukocyte activation processes in patients with chronic peripheral occlusive arterial disease: Role of L-propionyl carnitine administration 89
Genetic polymorphisms of FOXP3 in Italian patients with systemic sclerosis 88
Isoproterenol modulates matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor-2 (TIMP-2) in rat parotid gland 88
Preoperative rIL-2 treatment in renal cancer: Early and late effects on lymphocyte subsets and proliferation, NK activity, IL-6 in vivo and in vitro production 88
Obesity, Type 1 Diabetes, and Psoriasis: An Autoimmune Triple Flip 88
Jagged-1/Notch-1/Hes-1 pathway in psoriatic patients: effects of biological therapy 86
Regulation of drug and immune resistance by YY1 in cancer 85
Long pentraxin 3: a marker of inflammation in untreated psoriatic patients 85
Expression and localization of prominin-1 in isoproterenol-treated rat parotid gland 85
High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation 84
Insight into the role of microRNAs in brain tumors (review) 83
Novel NO-donating compound GIT-27NO possesses strong tumoricidal capacity in vitro and in vivo 83
Uterine cervical carcinoma: Role of matrix metalloproteinases (Review) 82
CIRCULATING IMMUNOCOMPLEXES AND LARYNGEAL CARCINOMA 82
Isoproterenol treatment modulates matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor-2 (TIMP-2) expression in rat parotid gland 82
Hormones are key actors in gene x environment interactions programming the vulnerability to Parkinson's disease: glia as a common final pathway 82
MAPK and AKT pathways are activated in melanoma by BRAF, NRAS and PIK3CA mutations 82
S100A7 in psoriasis: Immunodetection and activation by CRISPR technology 82
Dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappa B inhibitor, prevents inflammatory injury induced by interferon-gamma and histamine in NCTC 2544 keratinocytes 81
Immunohistocemical localization of NECL-5 in melanocytic skin lesions. Preliminary observations 80
Understanding rituximab function and resistance: implications for tailored therapy 80
Modulation of Chitotriosidase During Macrophage Differentiation 79
Effects of adalimumab, etanercept and ustekinumab on the expression of psoriasin (S100A7) in psoriatic skin 78
Venous stasis causes release of interleukin 1β (IL - 1β), interleukin 6 (IL – 6) and tumor necrosis factor alpha (TNFα) by monocite macrophage 77
Osteopontin and matrix metalloptroteinase-9 as markers of early detection of prostate cancer development 76
Frequency of bcl-2/IgH translocation in patients with non-Hodgkin's lymphoma and chronic hepatitis C virus infection 76
Lack of association of rs3761549 and rs5902434 polymorphisms of FOXP3 gene with risk of systemic sclerosis in the Italian population: A case-control study 76
Preventive and curative effects of cyclophosphamide in an animal model of Guillain Barre syndrome 76
Detection of bcl-2 rearrangement in mucosa-associated lymphoid tissue lymphomas from patients with hepatitis C virus infection 74
Prognostic significance of YY1 in High Grade Lymphomas 73
Immunolocalization of FOXP3 in HCV-infected liver biopsies. Preliminary observations 72
IL-6-174 G > C and MMP-9-1562 C > T polymorphisms are associated with increased risk of deep vein thrombosis in cancer patients. 72
Totale 11.480
Categoria #
all - tutte 39.648
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.648


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022691 0 107 0 8 126 6 113 24 75 0 15 217
2022/20231.167 117 53 20 105 124 212 2 202 269 12 40 11
2023/2024500 22 75 22 42 11 122 1 51 9 7 85 53
2024/20252.170 21 446 100 49 499 282 30 81 186 179 144 153
2025/20264.802 296 340 1.064 322 696 812 502 79 292 202 117 80
2026/2027340 124 216 0 0 0 0 0 0 0 0 0 0
Totale 11.953